HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Torgny Wilcke Selected Research

COVID-19

1/2022Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Torgny Wilcke Research Topics

Disease

9Chronic Obstructive Pulmonary Disease (COPD)
04/2024 - 04/2013
3Lung Diseases (Lung Disease)
09/2022 - 01/2018
1Cystic Fibrosis (Mucoviscidosis)
09/2022
1Asthma (Bronchial Asthma)
09/2022
1Bronchiectasis
09/2022
1COVID-19
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Bone Resorption
10/2020
1Airway Obstruction (Choking)
05/2019
1Meningitis
03/2011
1Pericarditis
03/2011
1Infections
03/2011

Drug/Important Bio-Agent (IBA)

4Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 03/2011
3Biomarkers (Surrogate Marker)IBA
04/2024 - 10/2020
3Anti-Bacterial Agents (Antibiotics)IBA
04/2024 - 07/2022
1FibrinIBA
08/2022
1omega-Chloroacetophenone (Mace)IBA
08/2022
1von Willebrand FactorIBA
08/2022
1GlucocorticoidsIBA
01/2022
1BNT162 VaccineIBA
01/2022
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2022
1insulin receptor-related receptor (IRR)IBA
05/2019
1Isoniazid (Ftivazide)FDA LinkGeneric
03/2011

Therapy/Procedure

3Therapeutics
09/2022 - 03/2011
2Palliative Care (Palliative Therapy)
01/2018 - 04/2013
1Aftercare (After-Treatment)
01/2022
1Telerehabilitation
10/2020
1Patient Readmission
01/2020
1Respiratory Therapy (Therapy, Respiratory)
05/2019